We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that is said to have the potential to end the HIV pandemic.

The WHO recommends lenacapavir, an HIV prevention drug, as global funding cuts threaten efforts to combat the epidemic. Learn about its impact and challenges.

US aid cuts halt HIV vaccine research in South Africa, with global impact The Associated Press July 14, 2025, 12:18 AM ...

(CNN) — The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially ...

The World Health Organisation (WHO) has called for the immediate global rollout of a breakthrough HIV drug, lenacapavir (LEN), that only requires two injections per year to offer near-total ...

JOHANNESBURG -- Just a week remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's ...

Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing services, spoke with MHE editors about her thoughts on the new ...

South Africa has played a historic, global role in scientific research, from COVID-19 vaccines to HIV. Now that's under threat after the Trump administration cut hundreds of millions of dollars ...

US aid cuts halt HIV vaccine research in South Africa, with global impact South Africa has been hit especially hard because of Trump's baseless claims about the targeting of the country's white ...

Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest ...

Global HIV gains at risk as funding crisis sparks urgent call to action Severe cuts to international aid are disrupting lifesaving HIV services in vulnerable countries, with UNAIDS warning of ...